Nothing fishy about this appointment.
Codiak has enjoyed enormous growth and interest recently and I assume Mr Haddock has been partly responsible.
PYC is quietly assembling the "Dream Team" (IMO). This team should open doors and aid the process through clinical trials and, hopefully FDA approval for conditions currently without treatment. That is, unless PYC gets taken out by an irresistable offer beforehand.
Nothing fishy about this appointment.Codiak has enjoyed enormous...
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$1.15 |
Change
0.020(1.77%) |
Mkt cap ! $670.7M | |||
| Open | High | Low | Value | Volume |
| $1.15 | $1.18 | $1.11 | $172.3K | 151.3K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 592 | $1.15 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.16 | 4211 | 1 |
View Market Depth
| Last trade - 16.10pm 20/06/2025 (20 minute delay) ? |
| PYC (ASX) Chart |